Care
The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.
MediOrbis will incorporate Kahun's AI tool into its platform to provide clinical insights to healthcare providers based on patients’ intake information.
The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.
The investment will support Nectar's growth nationwide, fund clinical trials and help the company open a physical location.
The startup offers access to advocates who can help family caregivers make plans or solve problems as well as a digital health platform.
Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.
However, these tools are not yet able to provide personalised advice.
The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.
The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."
Telemedicine use has declined since the height of the COVID-19 pandemic. Providers can rethink how they use telehealth to get the most out of the modality and improve care.